Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity National Information Services
FIS
|
+$513M |
| 2 |
Medtronic
MDT
|
+$477M |
| 3 |
Apple
AAPL
|
+$403M |
| 4 |
L3Harris
LHX
|
+$334M |
| 5 |
Danaher
DHR
|
+$249M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$433M |
| 2 |
AbbVie
ABBV
|
+$350M |
| 3 |
LLL
L3 Technologies, Inc.
LLL
|
+$315M |
| 4 |
CoStar Group
CSGP
|
+$273M |
| 5 |
Abbott
ABT
|
+$262M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.77% |
| 2 | Healthcare | 16.13% |
| 3 | Financials | 12.76% |
| 4 | Industrials | 11.58% |
| 5 | Consumer Discretionary | 10.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALTR
776
DELISTED
Altair Engineering Inc
ALTR
| $24.8M | 0.01% |
714,958
+67,438
| +10% | +$2.51M |
|
777
Philip Morris
PM
$305B
| $24.6M | 0.01% |
323,915
+21,466
| +7% | +$1.7M |
|
778
Snap-on
SNA
$21.1B
| $24.6M | 0.01% |
156,854
+6,821
| +5% | +$1.05M |
|
|
LK
779
DELISTED
Luckin Coffee Inc. American Depositary Shares
LK
| $24.6M | 0.01% |
1,292,118
+148
| +0% | +$3.13K |
|
780
Takeda Pharmaceutical
TAK
$55.7B
| $24.5M | 0.01% |
1,426,481
-54,006
| -4% | -$934K |
|
|
VER
781
DELISTED
VEREIT, Inc.
VER
| $24.4M | 0.01% |
499,533
+321,472
| +181% | +$15.2M |
|
|
MYOV
782
DELISTED
Myovant Sciences Ltd.
MYOV
| $24.1M | 0.01% |
4,627,784
+277,449
| +6% | +$2.06M |
|
783
East-West Bancorp
EWBC
$17.8B
| $24M | 0.01% |
542,499
-9,835
| -2% | -$432K |
|
784
Sanofi
SNY
$105B
| $24M | 0.01% |
517,508
-15,579
| -3% | -$672K |
|
|
AIV
785
Aimco
AIV
$377M
| $23.9M | 0.01% |
3,446,622
+329,602
| +11% | +$2.23M |
|
786
Stoke Therapeutics
STOK
$1.83B
| $23.9M | 0.01% |
1,144,575
+744,575
| +186% | +$20.8M |
|
787
Markel Group
MKL
$25.2B
| $23.8M | 0.01% |
20,145
-3,442
| -15% | -$3.91M |
|
788
Kontoor Brands
KTB
$4.74B
| $23.8M | 0.01% |
677,637
+562,870
| +490% | +$18.3M |
|
789
Prestige Consumer Healthcare
PBH
$2.39B
| $23.5M | 0.01% |
678,564
-1,214
| -0.2% | -$40K |
|
790
Voya Financial
VOYA
$8.98B
| $23.4M | 0.01% |
429,687
+350,116
| +440% | +$18.7M |
|
|
NP
791
DELISTED
Neenah, Inc. Common Stock
NP
| $23M | 0.01% |
353,859
+29,661
| +9% | +$1.93M |
|
792
iShares Russell 2000 ETF
IWM
$80.3B
| $23M | 0.01% |
+151,660
| New | +$23.2M |
|
793
Janus Henderson Short Duration Income ETF
VNLA
$3.33B
| $22.9M | 0.01% |
458,115
+248,716
| +119% | +$12.4M |
|
|
TRHC
794
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $22.9M | 0.01% |
416,785
+74,824
| +22% | +$4.28M |
|
|
TBI
795
Trueblue
TBI
$237M
| $22.9M | 0.01% |
1,084,227
-2,041
| -0.2% | -$42.2K |
|
796
LeMaitre Vascular
LMAT
$2.26B
| $22.9M | 0.01% |
668,694
+2,799
| +0.4% | +$89.4K |
|
797
HF Sinclair
DINO
$16.4B
| $22.7M | 0.01% |
422,614
-717,520
| -63% | -$34.8M |
|
798
Incyte
INCY
$23.7B
| $22.5M | 0.01% |
302,578
+51,665
| +21% | +$4.18M |
|
799
Snap
SNAP
$7.6B
| $22.4M | 0.01% |
1,418,818
+1,363,613
| +2,470% | +$21.8M |
|
800
Loews
L
$24.4B
| $22.2M | 0.01% |
431,610
+286,391
| +197% | +$14.8M |
|
Similar funds
Janus Henderson Group's Q3 2019 Portfolio in Review
As of Q3 2019, Janus Henderson Group held 1,465 positions worth $185B, up 0.14% from $184B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Janus Henderson Group's Q3 2019 filing shows 95 new, 675 increased, 602 reduced and 67 closed positions. Its largest new stake was Medtronic: 4,571,875 shares worth $497M. The largest sale was Mastercard, an estimated $433M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- Janus Henderson Group's largest Q3 2019 buy was Medtronic: 4,571,875 shares worth $497M.
- Janus Henderson Group added most to Fidelity National Information Services in Q3 2019, an estimated $513M increase.
- Janus Henderson Group's biggest Q3 2019 reduction was Mastercard, cutting an estimated $433M.
- Janus Henderson Group fully exited L3 Technologies, Inc. in Q3 2019, selling an estimated $315M.
- Janus Henderson Group's ten largest holdings make up 17% of its $185B portfolio in Q3 2019.
- Janus Henderson Group opened 95 new positions and closed 67 in Q3 2019.
- Janus Henderson Group's portfolio value rose 0.14% quarter-over-quarter to $185B.
Based on Janus Henderson Group's 13F filing for Q3 2019, filed 14 Nov 2019.